Patient-Centered Outcomes Research Institute (PCORI)

A cohort for type 2 diabetes studies

A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.

HCQ doesn’t protect health workers from COVID: study

Hydroxychloroquine (HCQ) did not significantly reduce the incidence of COVID-19 among health care workers who participated in a national study that included Vanderbilt University Medical Center.

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.

Tool guides decision-making for prostate cancer patients

Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.

Study uses IT to prevent early childhood obesity

A research team led by Vanderbilt University Medical Center’s Russell Rothman, MD, MPP, has been approved for a $7 million research funding award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a randomized, multi-center trial comparing clinic and consumer information technology approaches to promote healthy behaviors and prevent early childhood obesity.

Major award seeks to improve stroke outcomes

Vanderbilt’s Kenneth Gaines, MD, MBA, professor of Clinical Neurology, has received a $15.7 funding award to determine if stroke outcomes can be improved with a redesigned and better-integrated model of care.

1 2 3